"Kabi" Louvre Cell Treatment Kit - Taiwan Registration 76749791b38f1c2349f043d38f8da8a6
Access comprehensive regulatory information for "Kabi" Louvre Cell Treatment Kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 76749791b38f1c2349f043d38f8da8a6 and manufactured by Fresenius Kabi AG;; Fenwal International, Inc.. The authorized representative in Taiwan is FRESENIUS KABI TAIWAN LIMITED.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
76749791b38f1c2349f043d38f8da8a6
DHA05603439603
Product Details
This product is a single-use kit for the separation and preparation of blood components.
B Hematology, pathology, and genetics
B.9245 Automated hemocytoseparator
Input;; QMS/QSD
Dates and Status
Apr 19, 2021
Apr 19, 2026

